1 study found for:    Alkermes AND trip-2
Show Display Options
Rank Status Study
1 Completed
Has Results
ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Placebo;   Drug: TrIP-2D;   Drug: TrIP-2SS;   Drug: TrIP-2SS + Foradil

Indicates status has not been verified in more than two years